The antihypertensive profile of the angiotensin AT1 receptor antagonist, GR138950, and the influence of potential homeostatic compensatory mechanisms in renal hypertensive rats

British Journal of Pharmacology

Volumn 125, Issue 6, 1998, Pages 1236-1246

  Anderson, Ian K ^a,b   Drew, Geoffrey M ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b MEDIMMUNE LTD   (United Kingdom)

Author keywords

Angiotensin; Angiotensin AT1 receptors; Blood pressure; Enalapril; GR138950; Heart rate; Losartan; Renal hypertensive rats; Sympathetic nerve activity; Vasopressin

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ATENOLOL; ATROPINE METHYL NITRATE; SAPRISARTAN;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION; SPLANCHNIC NERVE; SYMPATHETIC NERVE; TACHYCARDIA;

EID: 0031773911     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702187     Document Type: Article

References (47)

1. AKERS, J.S., HILDITCH, A., ROBERTSON, M.J. & DREW, G.M. (1991). Does a relationship exist between the antihypertensive action and the angiotensin receptor antagonist activity of DuP753 in conscious rats? Br. J. Pharmacol., 104, 126P.
2. 1 receptor antagonist, GR138950. Br. J. Pharmacol., 122, 1385-1394.
3. 1 receptor antagonists, GR138950 and losartan, with enalapril in conscious renal hypertensive rats. Br. J. Pharmacol., 112, 44P.
4. AVERILL, D.B., TSUCHIHASHI, T., KHOSLA, M.C. & FERRARIO, C.M. (1994). Losartan, a nonpeptide angiotensin II-type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla. Brain Res., 665, 245-252.
5. BARRINGER, D.L. & BUÑAG, R.D. (1990). Differential anaesthetic depression of chronotropioc baroreflexes in rats. J. Cardiovasc. Pharmacol., 15, 10-15.
6. BATIN, P., GARDINER, S.M., COMPTON, A.M., KEMP, P.A. & BENNETT, T. (1991). Cardiac haemodynamic effects of the nonpeptide, angiotensin II-receptor antagonist, DuP753 in conscious Long Evans and Brattleboro rats. Br. J. Pharmacol., 103, 1585-1591.
7. BENNETT, T. & GARDINER, S.M. (1985). Involvement of vasopressin in cardiovascular control. Cardiovasc. Res., 19, 57-68.
8. BINDSCHEDLER, M., DEGEN, P., FLESCH, G., DE GASPARO, M. & PREISWERK, G. (1997). Pharmacokinetic and pharmacodynamic interaction of single oral doses of valsartan and furosemide. Eur. J. Clin. Pharmacol., 52, 371-378.
9. 1A-receptors play a role in the von Bezold-Jarisch reflex in the rat. Br. J. Pharmacol., 100, 757-760.
10. BREZENOFF, H.E., XIAO, Y. & VARGAS, H. (1988). A comparison of the central and peripheral antimuscarinic effects of atropine and methylatropine injected systemically and into the cerebral ventricles. Life Sci., 42, 905-911.
11. BROOKS, D.P., FREDRICKSON, T.A., WEINSTOCK, J., RUFFOLO, R.R., EDWARDS, R.M. & GELLAI. M. (1992). Antihypertensive activity of the non-peptide angiotensin II receptor antagonist, SK&F108566, in rats and dogs. Naunyn-Schmiedeberg Arch. Pharmacol., 345, 673-678.
12. BUCKINGHAM, R.E. & HAMILTON, T.C. (1979). β-adrenoceptor blocking drugs and hypertension. Gen. Pharmacol., 10, 1-13.
13. BUÑAG, R.D. & MIYAJIMA, E. (1984). Sympathetic hyperactivity elevates blood pressure during acute cerebroventricular infusions of hypertonic salt in rats. J. Cardiovasc. Pharmacol., 6, 844-851.
14. 1-receptor subtype. Br. J. Pharmacol., 110, 761-771.
15. DREW, G.M. (1993). Differences between angiotensin II antagonists. In Current Advances in ACE inhibition 3. ed. McGreggor, G.A., Sever, P., Caldwell, D. & Mernard, J. pp. 92-97. London: Churchill Livingstone.
16. EDMUNDS, M.E., RUSSELL, G.I., BURTON, P.R. & SWALES, J.D. (1990). Baroreceptor-heart rate reflex function before and after surgical reversal of two-kidney, one-clip hypertension in the rat. Circ. Res., 66, 1673-1680.
17. FINK, G.D. (1997). Long-term sympatho-excitatory effect of angiotensin II: a mechanism of spontaneous and renovascular hypertension. Clin. Exp. Pharmacol. Physiol., 24, 91-95.
18. FINK, G.D., BRUNER, C.A. & MANGIAPANE, M.L. (1987). Area postrema is critical for the angiotensin-induced hypertension in rats. Hypertension, 9, 355-361.
19. FINK, G.D., BRUNER, C.A., PAWLOSKI, C.M., BLAIR, M.L., SKOOG, K.M. & MANGIAPANE, M.L. (1986). Role of the area postrema in hypertension after unilateral renal artery constriction in the rats. Fed. Proc., 45, 875.
20. FINK, G.D., HAYWOOD, J.R., BRYAN, W.J., PACKWOOD, W. & BRODY, M.J. (1980). Central site of pressor action of blood-borne angiotensin in rat. Am. J. Physiol., 239, R358-R361.
21. GORBEA-OPPLIGER, V.J. & FINK, G.D. (1995). Cerebroventricular injection of angiotensin II antagonist: effects on blood pressure responses to central and systemic angiotensin II. J. Pharmacol. & Exp. Ther., 273, 611-616.
22. HATTON, R. & CLOUGH, D.P. (1982). Captopril interferes with neurogenic vasoconstriction in the pithed rat by angiotensin-dependent mechanisms. J. Cardiovasc. Pharmacol., 4, 116-123.
23. 1 receptor antagonist. Br. J. Pharmacol., 111, 137-144.
24. HILDITCH, A., HUNT, A.A., TRAVERS, A., POLLEY, J., DREW, G.M., MIDDLEMISS, D., JUDD, D.B., ROSS, B.C. & ROBERTSON, M.J. (1995). Pharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist. J. Pharmacol. Exp. Ther., 272, 750-757.
25. 1 receptor antagonist, GR138950. Br. J. Pharmacol., 118, 711-719.
26. HODGES, J.C., HAMBY, J.M. & BLANKLEY, C.J. (1992). Angiotensin II receptor binding inhibitors. Drugs of the Future, 17, 575-593.
27. HOGARTY, D.C., SPEAKMAN, E.A., PUIG, V. & PHILLIPS, M.I. (1992). The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin. Brain Res., 586, 289-294.
28. IOVINO, M. & STEARDO, L. (1984). Vasopressin release to central and peripheral angiotensin II in rats with lesions of the subfornical organ. Brain Res., 322, 365-368.
29. ITO, S. & SVED, A.F. (1996). Blockade of angiotensin receptors in rat rostral ventrolateral medulla removes excitatory vasomotor tone. Am. J. Physiol., 270, R1317-1323.
30. KRUSZYNSKI, M., LAMMEK, B. & MANNING, M. (1980). [1-(β-Mercapto-β,β-cyclopentamethylenepropionic acid), 2-(O-methyl)tyrosine]arginine-vasopressin and [1-(β-Mercapto-β,β-cyclopentamethylenepropionic acid)]arginine-vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressin. J. Med. Chem., 23, 364-368.
31. LEE, J.Y., BRUNE, M.E., WARNER, R.B., BUCKNER, S.B., WINN, S., DE, B., ZYDOWSKY, T.M., OPGENORTH, T.J., KERKMAN, D.J. & DEBERNARDIS, J.F. (1993). Antihypertensive activity of ABBOTT-81282, a nonpeptide angiotensin II antagonist, in the renal hypertensive rat. Pharmacology, 47, 176 187.
32. MANNING, M. & SAWYER, W.H. (1986). Synthesis and receptor specificities of vasopressin antagonists. J. Cardiovasc. Pharmacol., 8, (Suppl 7): S29-S35.
33. MOREAU, N., RICHER, C., VINCENT, M.-P. & GIUDICELLI, J.-F. (1993). Sympatoinhibitory effects of losartan in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol., 22, 126-134.
34. NIEDERBERGER, M., AUBERT, J.F., NUSSBERGER, J., BRUNNER, H.R. & WAEBER, B. (1995). Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin coverting enzyme inhibitor or an angiotensin II antagonist. J. Hypertens., 13, 439-445.
35. OHLSTEIN, E.H., GELLAI, M., BROOKS, D.P., VICKERY, L., JUGUS, J., SULPIZIO, A., RUFFOLO, R.R., WEINSTOCK, J. & EDWARDS, R.M. (1992). The antihypertensive effect of the angiotensin II receptor antagonist DuP753 may not be solely to angiotensin II receptor antagonism. J. Pharmacol. Exp. Ther., 262, 595-601.
36. SAKAI, S. & DAMPNEY, R.A.L. (1990). Tonic cardiovascular effects of angiotensin II in the ventrolateral medulla. Hypertension, 15, 274-283.
37. SIEGL, P.K., CHANG, R.S., MANTLO, N.B., CHAKRAVARTY, P.K., ONDEYKA, D.L., GREENLEE, W.J., PATCHETT, A.A., SWEET, C.S. & LOTTI, V.J. (1992). In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist. J. Pharmacol Exp. Ther., 262, 139-144.
38. STECKELINGS, U., LEBRUN, C., QADRI, F., VELTMAR, A. & UNGER, T. (1992). Role of brain angiotensin in cardiovascular regulation. J. Cardiovasc. Pharmacol., 19, (Suppl 6): S72- S79.
39. TAKISHITA, S., MURATANI, H., SESOKO, S., TERUYA, H., TOZAWA, M., FUKIYAMA, K. & INADA, Y. (1994). Short-term effects of angiotensin II blockade on renal blood flow and sympathetic activity in awake rats. Hypertension, 24, 445-450.
40. TSUNODA, K., ABE, K., HAGINO, T., OMATA, K., MISAWA, S., IMAI, Y. & YOSHINAGA, K. (1993). Hypotensive effect of losartan, a nonpeptide angiotensin II receptor antagonist, in essential hypertension. Am. J. Hypertens., 6, 28 32.
41. UNGER, T., BADOER, E., GANTEN, D., LANG, R.E. & RETTIG, R. (1988). Brain angiotensin: pathways and pharmacology. Circulation, 77, (Suppl 1): 1-40.
42. UNGER, T., BECKER, H., PETTY, M., DEMMERT, G., SCHNEIDER, B., GANTEN, D. & LANG, R.E. (1985). Differential effects of central angiotensin II and substance P on sympathetic nerve activity in conscious rats. Implications for cardiovascular adaptation to behavioral responses. Circ. Res., 56, 563-575.
43. WONG, P.C., PRICE, W.A., CHIU, A.T., DUNCIA, J.V., CARINI, D.J., WEXLER, R.R., JOHNSON, A.L. & TIMMERMANS, P.B.M.W.M. (1990). Hypotensive action of DuP753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists. X. Hypertension. 15, 459 468.
44. WONG, P.C., PRICE, W.A., REILLY, T.M., DUNCIA, J.V. & TIMMERMANS, P.B.M.W.M. (1989a). Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a non-peptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody. J. Pharmacol. Exp. Ther., 250, 515-522.
45. WONG, P.C., REILLY, T.M. & TIMMERMANS, P.B.M.W.M. (1989b). Effect of a monoclonal antibody to angiotensin II on haemodynamic responses to noradrenergic stimulation in pithed rats. Hypertension, 14, 488-497.
46. XU, L. & BROOKS, V.L. (1996). Ang II chronically supports renal and lumbar sympathetic activity in sodium-deprived, conscious rats. Am. J. Physiol., 271, H2591-H2598.
47. YANG, H., JIN, H., WYSS, J.M. & OPARIL, S. (1992). Depressor effect of blocking angiotensin subtype I receptors in anterior hypothalamus. Hypertension, 19, 475-481.